サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1800786

分子細胞遺伝学市場レポート：製品タイプ、技術、用途、エンドユーザー、地域別、2025～2033年

Molecular Cytogenetics Market Report by Product Type, Technology (Comparative Genomic Hybridization, Fluorescence in SITU Hybridization, Immunohistochemistry, Karyotyping, and Others), Application, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 123 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.25円
分子細胞遺伝学市場レポート：製品タイプ、技術、用途、エンドユーザー、地域別、2025～2033年
出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 123 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の分子細胞遺伝学市場規模は2024年に29億米ドルに達しました。今後、IMARC Groupは、同市場が2033年までに64億米ドルに達し、2025～2033年の成長率（CAGR）は8.63％に達すると予測しています。

分子細胞遺伝学遺伝子変異や障害を調査するためのデオキシリボ核酸（DNA）メカニズムの生物医学的調査を指します。染色体やその核の構造的・機能的組織、ゲノムの変異、発現、進化、異常などを研究し、特に医薬品やがん関連の遺伝学を研究します。DNA増幅、DNA単離、遺伝子スクリーニング、仮想核型分析、蛍光in situハイブリダイゼーション（FISH）などの技術は、DNAプローブを用いてゲノムまたはその標的領域を可視化し標識することにより、分子細胞遺伝学に一般的に使用されています。これらの技術は、様々な悪性腫瘍や血液悪性腫瘍の診断や治療に非常に有益です。

がんやその他の遺伝性疾患の有病率の増加、高齢者人口の増加は、市場の成長を促進する重要な要因の一つです。分子細胞遺伝学は主に、疾患特性の予測モデルや効果的な治療戦略の開発に利用されています。さらに、がん治療に標的療法が広く採用されていることも、市場の成長を後押ししています。FISHおよび比較ゲノムハイブリダイゼーション（CGH）は、がんの進行段階を分析し、患者に個別化治療を提供するための薬理ゲノムバイオマーカー研究にも使用されています。さらに、改良された消耗品、試薬、ソフトウェア、キットの開発など、さまざまな技術的進歩が他の成長促進要因として作用しています。これらの進歩は、複製可能で正確かつ信頼性の高い臨床病理学的検査結果の生成に役立っています。その他の要因としては、ヘルスケアインフラの大幅な改善、バイオメディカル科学分野における広範な研究開発（R&D）活動などがあり、市場をさらに牽引すると予想されます。

本レポートで扱う主な質問

  • 2024年の世界の分子細胞遺伝学市場規模は？
  • 2025年～2033年の分子細胞遺伝学世界市場の予想成長率は？
  • 分子細胞遺伝学の世界市場に対するCOVID-19の影響は？
  • 分子細胞遺伝学の世界市場を牽引する主要因は？
  • 分子細胞遺伝学の世界市場における製品タイプ別の区分は？
  • 分子細胞遺伝学の世界市場における技術別の区分は？
  • 分子細胞遺伝学の世界市場における用途別の区分は？
  • 分子細胞遺伝学の世界市場におけるエンドユーザー別の区分は？
  • 分子細胞遺伝学の世界市場における主要地域は？
  • 分子細胞遺伝学の世界市場における主要企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の分子細胞遺伝学市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品タイプ別

  • 機器
  • 消耗品
  • ソフトウェアとサービス
  • その他

第7章 市場内訳：技術別

  • 比較ゲノムハイブリダイゼーション
  • SITUハイブリダイゼーションにおける蛍光（FISH）
  • 免疫組織化学
  • 核型分析
  • その他

第8章 市場内訳：用途別

  • 遺伝性疾患
  • 腫瘍学
  • パーソナライズ医療
  • その他

第9章 市場内訳：エンドユーザー別

  • 臨床調査室
  • 病院および病理学研究所
  • 製薬およびバイオテクノロジー企業
  • その他

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ

第11章 SWOT分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Agilent Technologies Inc.
    • Applied Spectral Imaging Inc.
    • Biological Industries
    • Bio-RAD Laboratories Inc.
    • BioView Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Illumina Inc.
    • Oxford Gene Technology
    • Perkinelmer Inc.
    • Quest Diagnostics Incorporated
図表

List of Figures

  • Figure 1: Global: Molecular Cytogenetics Market: Major Drivers and Challenges
  • Figure 2: Global: Molecular Cytogenetics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Molecular Cytogenetics Market: Breakup by Product Type (in %), 2024
  • Figure 4: Global: Molecular Cytogenetics Market: Breakup by Technology (in %), 2024
  • Figure 5: Global: Molecular Cytogenetics Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Molecular Cytogenetics Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Molecular Cytogenetics Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Molecular Cytogenetics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 9: Global: Molecular Cytogenetics (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Molecular Cytogenetics (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Molecular Cytogenetics (Consumables) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Molecular Cytogenetics (Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Molecular Cytogenetics (Software and Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Molecular Cytogenetics (Software and Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Molecular Cytogenetics (Other Product Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Molecular Cytogenetics (Other Product Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Molecular Cytogenetics (Comparative Genomic Hybridization) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Molecular Cytogenetics (Comparative Genomic Hybridization) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Molecular Cytogenetics (Fluorescence in SITU Hybridization - FISH) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Molecular Cytogenetics (Fluorescence in SITU Hybridization - FISH) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Molecular Cytogenetics (Immunohistochemistry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Molecular Cytogenetics (Immunohistochemistry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Molecular Cytogenetics (Karyotyping) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Molecular Cytogenetics (Karyotyping) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Molecular Cytogenetics (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Molecular Cytogenetics (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Molecular Cytogenetics (Genetic Disorders) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Molecular Cytogenetics (Genetic Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Molecular Cytogenetics (Oncology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Molecular Cytogenetics (Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Molecular Cytogenetics (Personalized Medicine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Molecular Cytogenetics (Personalized Medicine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Molecular Cytogenetics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Molecular Cytogenetics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Molecular Cytogenetics (Clinical and Research Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Molecular Cytogenetics (Clinical and Research Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Molecular Cytogenetics (Hospitals and Pathology Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Molecular Cytogenetics (Hospitals and Pathology Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Molecular Cytogenetics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Molecular Cytogenetics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Global: Molecular Cytogenetics (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Global: Molecular Cytogenetics (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: North America: Molecular Cytogenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: North America: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: United States: Molecular Cytogenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: United States: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Canada: Molecular Cytogenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Canada: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Asia Pacific: Molecular Cytogenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Asia Pacific: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: China: Molecular Cytogenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: China: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Japan: Molecular Cytogenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Japan: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: India: Molecular Cytogenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: India: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: South Korea: Molecular Cytogenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: South Korea: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Australia: Molecular Cytogenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Australia: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Indonesia: Molecular Cytogenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Indonesia: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Others: Molecular Cytogenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Others: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Europe: Molecular Cytogenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Europe: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Germany: Molecular Cytogenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Germany: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: France: Molecular Cytogenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: France: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: United Kingdom: Molecular Cytogenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: United Kingdom: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Italy: Molecular Cytogenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Italy: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Spain: Molecular Cytogenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Spain: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Russia: Molecular Cytogenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Russia: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Others: Molecular Cytogenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Others: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Latin America: Molecular Cytogenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Latin America: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Brazil: Molecular Cytogenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Brazil: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Mexico: Molecular Cytogenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Mexico: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Others: Molecular Cytogenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Others: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Middle East and Africa: Molecular Cytogenetics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 90: Middle East and Africa: Molecular Cytogenetics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 91: Global: Molecular Cytogenetics Industry: SWOT Analysis
  • Figure 92: Global: Molecular Cytogenetics Industry: Value Chain Analysis
  • Figure 93: Global: Molecular Cytogenetics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Molecular Cytogenetics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Molecular Cytogenetics Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Molecular Cytogenetics Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 4: Global: Molecular Cytogenetics Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Molecular Cytogenetics Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Molecular Cytogenetics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Molecular Cytogenetics Market Structure
  • Table 8: Global: Molecular Cytogenetics Market: Key Players
目次
Product Code: SR112025A2623

The global molecular cytogenetics market size reached USD 2.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.4 Billion by 2033, exhibiting a growth rate (CAGR) of 8.63% during 2025-2033.

Molecular cytogenetics refers to the biomedical research of deoxyribonucleic acid (DNA) mechanisms to investigate genetic mutations and disorders. It studies the structural and functional organization of the chromosomes and their nucleus, genomic variations, expression, evolution and abnormalities, especially in medicinal and cancer-related genetics. Techniques such as DNA amplification, DNA isolation, gene screens, virtual karyotyping and fluorescence in situ hybridization (FISH) are commonly used for molecular cytogenetics by using DNA probes to visualize and label the genome or its targeted regions. These techniques are highly beneficial in the diagnosis and treatment of various malignant tumors and hematological malignancies.

The increasing prevalence of cancer and other genetic disorders, along with the rising geriatric population, is one of the key factors driving the growth of the market. Molecular cytogenetics is primarily being used for developing predictive models of disease traits and effective treatment strategies. Furthermore, the widespread adoption of targeted therapies for cancer treatment is also augmenting the market growth. FISH and Comparative Genomic Hybridization (CGH) are also used for pharmacogenomic biomarker studies to analyze cancer progression stages and provide personalized treatment to the patient. Additionally, various technological advancements, such as the development of improved consumables, reagents, software and kits, are acting as other growth-inducing factors. These advancements aid in generating duplicatable, accurate and reliable clinical-pathological test results. Other factors, including significant improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities in the field of biomedical sciences, are anticipated to drive the market further.

Key Market Segmentation:

Breakup by Product Type:

  • Instruments
  • Consumables
  • Software and Services
  • Others

Breakup by Technology:

  • Comparative Genomic Hybridization
  • Fluorescence in SITU Hybridization (FISH)
  • Immunohistochemistry
  • Karyotyping
  • Others

Breakup by Application:

  • Genetic Disorders
  • Oncology
  • Personalized Medicine
  • Others

Breakup by End User:

  • Clinical and Research Laboratories
  • Hospitals and Pathology Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Agilent Technologies Inc., Applied Spectral Imaging Inc., Biological Industries, Bio-RAD Laboratories Inc., BioView Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Illumina Inc., Oxford Gene Technology, Perkinelmer Inc. and Quest Diagnostics Incorporated.

Key Questions Answered in This Report

  • 1.What was the size of the global molecular cytogenetics market in 2024?
  • 2.What is the expected growth rate of the global molecular cytogenetics market during 2025-2033?
  • 3.What has been the impact of COVID-19 on the global molecular cytogenetics market?
  • 4.What are the key factors driving the global molecular cytogenetics market?
  • 5.What is the breakup of the global molecular cytogenetics market based on the product type?
  • 6.What is the breakup of the global molecular cytogenetics market based on the technology?
  • 7.What is the breakup of the global molecular cytogenetics market based on application?
  • 8.What is the breakup of the global molecular cytogenetics market based on the end user?
  • 9.What are the key regions in the global molecular cytogenetics market?
  • 10.Who are the key players/companies in the global molecular cytogenetics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Molecular Cytogenetics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Comparative Genomic Hybridization
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Fluorescence in SITU Hybridization (FISH)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Immunohistochemistry
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Karyotyping
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Genetic Disorders
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oncology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Personalized Medicine
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Clinical and Research Laboratories
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals and Pathology Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Agilent Technologies Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Applied Spectral Imaging Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Biological Industries
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Bio-RAD Laboratories Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 BioView Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Danaher Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 F. Hoffmann-La Roche AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 SWOT Analysis
    • 15.3.9 Illumina Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Oxford Gene Technology
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Perkinelmer Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Quest Diagnostics Incorporated
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials